Despite increasing evidence linking S100 protein expression to bladder cancer stage, grade, and prognosis, most existing studies have not comprehensively accounted for molecular subtype specificity or adjusted for clinical confounders. The gene discussed is S100A1; the disease is urinary bladder cancer.